Around the Net
Mylan CEO Gets Bipartisan Boos Over EpiPen Price Hike
- USA Today, Thursday, September 22, 2016 8:03 AM
The CEO of the drug maker that sells the EpiPen allergy-reaction injector defended the company's six-fold price increases Wednesday in congressional testimony, painting the lifesaving treatment as less profitable than it might appear. Heather Bresch was assailed in a bipartisan chorus over the increases. EpiPen has gone from $100 for a two-pack in 2009 to $608 today.
